HEMOLYTIC ANEMIA

Clinical trials for HEMOLYTIC ANEMIA explained in plain language.

Never miss a new study

Get alerted when new HEMOLYTIC ANEMIA trials appear

Sign up with your email to follow new studies for HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Sickle cell drug mitapivat faces Long-Term safety check in small study

Disease control Ongoing

This study looks at the long-term safety and tolerability of the drug mitapivat in adults with stable sickle cell disease. Participants, who previously benefited from mitapivat in an earlier study, take the drug twice daily for up to 48 weeks, with an option to continue for anoth…

Matched conditions: HEMOLYTIC ANEMIA

Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC

HEMOLYTIC ANEMIA

Get alerted when new HEMOLYTIC ANEMIA trials appear

Sickle cell drug mitapivat faces Long-Term safety check in small study